TELA Bio Inc has a consensus price target of $14, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, Piper Sandler, and Lake Street on March 22, 2024, March 22, 2024, and December 27, 2023. With an average price target of $13.67 between JMP Securities, Piper Sandler, and Lake Street, there's an implied 199.05% upside for TELA Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/22/2024 | TELA | Buy Now | TELA Bio | $4.57 | 228.23% | JMP Securities | David Turkaly | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/22/2024 | TELA | Buy Now | TELA Bio | $4.57 | 162.58% | Piper Sandler | Matt O'Brien | $15 → $12 | Maintains | Overweight | Get Alert |
12/27/2023 | TELA | Buy Now | TELA Bio | $4.57 | 206.35% | Lake Street | Frank Takkinen | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
11/10/2023 | TELA | Buy Now | TELA Bio | $4.57 | 228.23% | JMP Securities | David Turkaly | $20 → $15 | Maintains | Market Outperform | Get Alert |
03/28/2023 | TELA | Buy Now | TELA Bio | $4.57 | 228.23% | Canaccord Genuity | Kyle Rose | → $15 | Reiterates | → Buy | Get Alert |
03/22/2023 | TELA | Buy Now | TELA Bio | $4.57 | 337.64% | JMP Securities | David Turkaly | → $20 | Reiterates | → Market Outperform | Get Alert |
11/10/2022 | TELA | Buy Now | TELA Bio | $4.57 | 337.64% | JMP Securities | David Turkaly | $22 → $20 | Maintains | Market Outperform | Get Alert |
11/10/2022 | TELA | Buy Now | TELA Bio | $4.57 | 228.23% | Piper Sandler | Matt O'Brien | $20 → $15 | Maintains | Overweight | Get Alert |
The latest price target for TELA Bio (NASDAQ: TELA) was reported by JMP Securities on March 22, 2024. The analyst firm set a price target for $15.00 expecting TELA to rise to within 12 months (a possible 228.23% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for TELA Bio (NASDAQ: TELA) was provided by JMP Securities, and TELA Bio reiterated their market outperform rating.
There is no last upgrade for TELA Bio.
There is no last downgrade for TELA Bio.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TELA Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TELA Bio was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
While ratings are subjective and will change, the latest TELA Bio (TELA) rating was a reiterated with a price target of $0.00 to $15.00. The current price TELA Bio (TELA) is trading at is $4.57, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.